San Diego Life Sciences Roundup: Shire, Thesan, ViaCyte, and More

11/2/12Follow @bvbigelow

What do Thesan Pharmaceuticals, ViaCyte, and Reflexion Health have in common? Each one disclosed that it raised a significant amount of capital. We have that and more.

—San Diego’s Thesan Pharmaceuticals, a newly formed biotech developing innovative drugs for dermatological disorders, said it closed on a $16 million Series A round of financing that was co-led by Novo Ventures and Novartis Venture Funds. Thesan says its lead drug candidate is a topically applied compound expected to enter the clinic in 2013. The company’s first products were licensed from the University of California, Irvine, where they were developed in the laboratory of Daniele Piomelli.

—It’s not exactly teleportation, but famed geneticist J. Craig Venter says it would be possible to transmit an organism from Mars back to earth using a process he calls digital biological conversion. The idea is to put a robotic genetic sequencer aboard a Mars rover, and use it to sequence the genomes of any microbes found in soil samples. The rover could transmit the data to Earth, where the sequenced genome could be used to replicate Martian organisms here on Earth.

—The California Institute for Regenerative Medicine (CIRM) has awarded a $10.1 million grant to San Diego-based ViaCyte to move the diabetes company’s stem cell and cell encapsulation technologies into human clinical trials. ViaCyte has developed technology that uses embryonic stem cells to make large quantities of safe and functional islet cells, capable of producing insulin that could be used to treat patients with insulin-dependent Type 1 and Type 2 diabetes. ViaCyte would then encapsulate the engineered cells in packets that can be implanted beneath the skin, producing what the company calls an “artificial pancreas.”

—The West Health Investment Fund has provided $4.25 million in funding for Reflexion Health, a San Diego startup developing technology that uses Microsoft’s Kinect motion sensing system to help physical therapy patients with their rehab. The West Health Institute licensed the … Next Page »

Bruce V. Bigelow is the editor of Xconomy San Diego. You can e-mail him at bbigelow@xconomy.com or call (619) 669-8788 Follow @bvbigelow

Single Page Currently on Page: 1 2

By posting a comment, you agree to our terms and conditions.